1)Coleman AL, Miglior S:Risk factors for glaucoma onset and progression. Surv Ophthalmol 53(Suppl 1):3-10, 2008
2)Brandt JD, Beiser JA, Kass MA et al:Central corneal thickness in the ocular hypertension treatment study(OHTS). Ophthalmology 108:1779-1788, 2001
3)Medeiros FA, Sample PA, Weinreb RN:Corneal thickness measurements and frequency doubling technology perimetry abnormalities in ocular hypertensive eyes. Ophthalmology 110:1903-1908, 2003
4)Mohamed-Noor J, Bochmann F, Siddiqui MA et al:Correlation between corneal and scleral thickness in glaucoma. J Glaucoma 18:32-36, 2009
5)Manni G, Oddone F, Parisi V et al:Intraocular pressure and central corneal thickness. Prog Brain Res 173:25-30, 2008
6)Shih CY, Graff Zivin JS, Trokel SL et al:Clinical significance of central corneal thickness in the management of glaucoma. Arch Ophthalmol 122:1270-1275, 2004
7)Foster PJ, Buhrmann R, Quigly HA et al:The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol 86:238-242, 2002
8)日本緑内障学会:緑内障診療ガイドライン(第2版).日眼会誌 110:777-814,2006
9)Iwase A, Araie M, Tomidokoro A et al:Prevalence and cause of low vision and blindness in a Japanese adult population. The Tajimi Study. Ophthalmology 113:1354-1362, 2006
10)Iwase A, Suzuki Y, Araie M et al:The prevalence of primary open-angle glaucoma in Japanese. The Tajimi Study. Ophthalmology 111:1641-1648, 2004
11)Yamamoto T, Iwase A, Araie M et al:The Tajimi Study Report 2. Prevalence of primary angle closure and secondary glaucoma in a Japanese population. Ophthalmology 112:1661-1669, 2005
12)Suzuki Y, Iwase A, Araie M et al:Risk factors for open-angle glaucoma in a Japanese population. The Tajimi Study. Ophthalmology 113:1613-1617, 2006
13)Kass MA, Heuer DK, Higginbotham EJ et al:The Ocular Hypertension Treatment Study. Arch Ophthalmol 120:701-713, 2002
14)Tomidokoro A, Araie M, Iwase A;Tajimi Study Group:Corneal thickness and relating factors in a population-based study in Japan:The Tajimi Study. Am J Ophthalmol 144:152-154, 2007
15)Wu LL, Suzuki Y, Ideta R et al:Central corneal thickness of normal tension glaucoma patients in Japan. Jpn J Ophthalmol 44:643-647, 2000
16)Gordon MO, Beiser JA, Brandt JD et al:The Ocular Hypertension Treatment Study:baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120:714-720, 2002
17)Brandt JD, Beiser JA, Gordon MO et al:Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study. Am J Ophthalmol 138:717-722, 2004
18)Leske MC, Heijl A, Hussein M et al:Factors for glaucoma progression and the effect of treatment:the early manifest glaucoma trial. Arch Ophthalmol 121:48-56, 2003
19)Brandt JD:Central corneal thickness, tonometry, and glaucoma risk:a guide for the perplexed. Can J Ophthalmol 42:562-566, 2007
20)Kotecha A:What biomechanical properties of cornea are relevant for the clinicians? Surv Ophthalmol 52(Suppl 2):109-114, 2007